<div id="readability-page-1"><div>Collagen Hydrolysates Market Growth Fueled by Shift Toward Fermentation-Derived Alternatives, Bioactive Peptides, and &#34;Beauty-from-Within&#34; Trends NEWARK, DE / ACCESS Newswire / March 5, 2026 / The global collagen hydrolysates sector is undergoing a profound transformation, transitioning from a generic supplement into a scientifically-backed &#34;functional powerhouse&#34; driven by clinical validation and a surge in sustainable biotechnology. According to the latest strategic outlook by Future Market Insights (FMI), the global Collagen Hydrolysates Market valued at USD 1.4 Billion in 2026-is projected to reach USD 3.0 Billion by 2036, expanding at a robust 7.8% CAGR.The report identifies a critical pivot: consumers and manufacturers are moving beyond basic gelatin to embrace bioactive, condition-specific peptides that offer targeted benefits for joint mobility, skin elasticity, and gut health. This evolution is spearheaded by a shift toward high-purity extraction technologies and the groundbreaking emergence of non-animal, fermentation-derived alternatives. <img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/imagelibrary/23adc0de-3586-4f90-8ee1-5d87a9e004bc/1143517/collagen-hydrolysates-market.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1536" height="1024" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/imagelibrary/23adc0de-3586-4f90-8ee1-5d87a9e004bc/1143517/collagen-hydrolysates-market.png"/> Get Access to the Full Report Sample: Explore detailed forecasts, segment insights, and competitive analysis: https://www.futuremarketinsights.com/reports/sample/rep-gb-14908The Pivot to &#34;Clinical Substantiation&#34; and Sustainable SourcingA primary driver for this decade-long expansion is the &#34;medicalization&#34; of the supplement aisle. FMI notes that as &#34;beauty-from-within&#34; trends gain mainstream traction, consumers are demanding proof of efficacy.&#34;Collagen is no longer just about marketing hype; it is now a delivery vehicle for proven health outcomes,&#34; notes a senior FMI analyst. &#34;We are seeing a massive influx of IP-backed products where clinical trials measuring serum peptide levels are used to justify premium pricing. In early 2025, the FDA's GRAS Notice Inventory confirmation of fermentation-derived collagen has provided a massive regulatory green light for the vegan-friendly sector.&#34;Segment Insights: The Power of Animal-Based Sources and Nutraceutical Dominance<ul><li>Animal-Based Segment (65.0% Share): This segment maintains a dominant stronghold due to established global supply chains and the cost-effective availability of Type I and III collagen from bovine and porcine sources.</li><li>Nutraceuticals (45.0% Share): Leading the application category, nutraceuticals are fueled by an aging global population seeking preventative measures for joint and bone health.</li><li>Powder Formats (48.0% Share): Powder remains the leading form due to its high solubility and versatility in sports nutrition and functional beverages, though gummies and liquid shots are seeing rapid growth in the &#34;lifestyle&#34; category.</li></ul>Regional Performance: China and Japan Lead the High-Growth FrontierWhile North America remains a center for clean-label innovation, the highest velocity of growth is concentrated in the Asia-Pacific region:<ul><li>China (8.4% CAGR): Leading the global growth curve, China is modernizing its massive manufacturing base to meet international regulatory standards while satisfying surging domestic demand.</li><li>Japan (7.9% CAGR): Driven by a sophisticated aesthetic culture and a high elderly population, Japan prioritizes low-molecular-weight peptides with superior absorption rates.</li><li>United States (7.5% CAGR): Sustained by the integration of collagen into performance nutrition and the rise of biotech &#34;challenger&#34; brands focused on animal-free alternatives.</li></ul>Competitive Landscape: IP Protection and Bioactive EcosystemsThe market is characterized by intense competition as legacy gelatin producers transition into &#34;bioactive&#34; ingredient specialists.Key Players include: Gelita AG, Rousselot (Darling Ingredients), PB Leiner, Wellnex (Nitta Gelatin Inc.), Geltor, Nippi Collagen, Garden of Life, Orgain, and Viscofan BioEngineering.Strategic highlights include Rousselot's recent European patent for its &#34;Colartix&#34; joint health matrix and Geltor's focus on &#34;bio-designed&#34; ingredients that allow iconic brands to build sustainable, animal-free products. As Kurt Seidensticker, Founder of Vital Proteins, suggests, &#34;Manufacturing scalability and agility are now prerequisites for capturing mass-market adoption.&#34;Unlock In-Depth Market Intelligence - Access the Full Report Now: https://www.futuremarketinsights.com/reports/collagen-hydrolysates-marketWhy FMI: https://www.futuremarketinsights.com/why-fmiRelated Reports:Pet Cardiovascular Health Supplement Market: https://www.futuremarketinsights.com/reports/pet-cardiovascular-health-supplement-marketPet Joint Health Supplements Market: https://www.futuremarketinsights.com/reports/pet-joint-health-supplements-marketReady-To-Roll (RTR) Icings Market: https://www.futuremarketinsights.com/reports/ready-to-roll-rtr-icings-marketFish-Based Pet Food Market: https://www.futuremarketinsights.com/reports/fish-based-pet-food-marketEurope Savory Ingredients Market: https://www.futuremarketinsights.com/reports/europe-savory-ingredients-marketAbout Future Market Insights (FMI)Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.For Press &amp; Corporate InquiriesRahul Singh AVP - Marketing and Growth Strategy Future Market Insights, Inc. +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/SOURCE: Future Market Insights, Inc.View the original press release on ACCESS Newswire <img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTE0MzUxNw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTE0MzUxNw"/></div></div>

IBBQ

納斯達克生物科技指數 ETF - iShares Nasdaq

全球膠原蛋白水解物市場預計將從 2026 年的 14 億美元增長到 2036 年的 30 億美元，年均增長率為 7.8%。這一增長受到向生物活性肽和發酵衍生替代品轉變的推動，因為消費者對健康益處的臨牀驗證提出了需求。該市場主要由動物來源主導，特別是在營養保健品領域，亞太地區，尤其是中國和日本，增長顯著。主要參與者包括 Gelita AG 和 Rousselot，專注於生物活性成分和可持續實踐

隨着臨牀驗證和生物技術創新重新定義健康，膠原蛋白水解物市場預計到 2036 年將達到 30 億美元